Trial intelligence / Profile preview

Comparison of rocuronium dosing based on total body weight and skeletal muscle mass

KCT0004829Phase 4Not yet recruiting

Sponsor
Jeonbuk National University Hospital
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rocuronium, sponsored by Jeonbuk National University Hospital. Planned start Mar 2020; status: not yet recruiting.

02

Drugs

rocuronium

Beyond the preview

Go deeper on KCT0004829.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004829.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call